Pediatric Respiratory Disease Therapeutics Market, Global Outlook and Forecast 2024-2031

Report ID: 1068342 | Published Date: Jan 2025 | No. of Page: 62 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Pediatric Respiratory Disease Therapeutics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Pediatric Respiratory Disease Therapeutics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Pediatric Respiratory Disease Therapeutics Overall Market Size
    2.1 Global Pediatric Respiratory Disease Therapeutics Market Size: 2021 VS 2028
    2.2 Global Pediatric Respiratory Disease Therapeutics Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Pediatric Respiratory Disease Therapeutics Players in Global Market
    3.2 Top Global Pediatric Respiratory Disease Therapeutics Companies Ranked by Revenue
    3.3 Global Pediatric Respiratory Disease Therapeutics Revenue by Companies
    3.4 Top 3 and Top 5 Pediatric Respiratory Disease Therapeutics Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Pediatric Respiratory Disease Therapeutics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Pediatric Respiratory Disease Therapeutics Players in Global Market
        3.6.1 List of Global Tier 1 Pediatric Respiratory Disease Therapeutics Companies
        3.6.2 List of Global Tier 2 and Tier 3 Pediatric Respiratory Disease Therapeutics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Pediatric Respiratory Disease Therapeutics Market Size Markets, 2021 & 2028
        4.1.2 Anti-Inflammatory Drugs
        4.1.3 Bronchodilators
        4.1.4 Combination Drugs
        4.1.5 Corticosteroid
        4.1.6 Monoclonal Antibodies
        4.1.7 Others
    4.2 By Type - Global Pediatric Respiratory Disease Therapeutics Revenue & Forecasts
        4.2.1 By Type - Global Pediatric Respiratory Disease Therapeutics Revenue, 2017-2022
        4.2.2 By Type - Global Pediatric Respiratory Disease Therapeutics Revenue, 2023-2028
        4.2.3 By Type - Global Pediatric Respiratory Disease Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Pediatric Respiratory Disease Therapeutics Market Size, 2021 & 2028
        5.1.2 Asthma
        5.1.3 Cystic Fibrosis
        5.1.4 Bronchiolitis
        5.1.5 Pneumonia
        5.1.6 Idiopathic Pulmonary Fibrosis
        5.1.7 Tuberculosis
        5.1.8 Others
    5.2 By Application - Global Pediatric Respiratory Disease Therapeutics Revenue & Forecasts
        5.2.1 By Application - Global Pediatric Respiratory Disease Therapeutics Revenue, 2017-2022
        5.2.2 By Application - Global Pediatric Respiratory Disease Therapeutics Revenue, 2023-2028
        5.2.3 By Application - Global Pediatric Respiratory Disease Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Pediatric Respiratory Disease Therapeutics Market Size, 2021 & 2028
    6.2 By Region - Global Pediatric Respiratory Disease Therapeutics Revenue & Forecasts
        6.2.1 By Region - Global Pediatric Respiratory Disease Therapeutics Revenue, 2017-2022
        6.2.2 By Region - Global Pediatric Respiratory Disease Therapeutics Revenue, 2023-2028
        6.2.3 By Region - Global Pediatric Respiratory Disease Therapeutics Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Pediatric Respiratory Disease Therapeutics Revenue, 2017-2028
        6.3.2 US Pediatric Respiratory Disease Therapeutics Market Size, 2017-2028
        6.3.3 Canada Pediatric Respiratory Disease Therapeutics Market Size, 2017-2028
        6.3.4 Mexico Pediatric Respiratory Disease Therapeutics Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Pediatric Respiratory Disease Therapeutics Revenue, 2017-2028
        6.4.2 Germany Pediatric Respiratory Disease Therapeutics Market Size, 2017-2028
        6.4.3 France Pediatric Respiratory Disease Therapeutics Market Size, 2017-2028
        6.4.4 U.K. Pediatric Respiratory Disease Therapeutics Market Size, 2017-2028
        6.4.5 Italy Pediatric Respiratory Disease Therapeutics Market Size, 2017-2028
        6.4.6 Russia Pediatric Respiratory Disease Therapeutics Market Size, 2017-2028
        6.4.7 Nordic Countries Pediatric Respiratory Disease Therapeutics Market Size, 2017-2028
        6.4.8 Benelux Pediatric Respiratory Disease Therapeutics Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Pediatric Respiratory Disease Therapeutics Revenue, 2017-2028
        6.5.2 China Pediatric Respiratory Disease Therapeutics Market Size, 2017-2028
        6.5.3 Japan Pediatric Respiratory Disease Therapeutics Market Size, 2017-2028
        6.5.4 South Korea Pediatric Respiratory Disease Therapeutics Market Size, 2017-2028
        6.5.5 Southeast Asia Pediatric Respiratory Disease Therapeutics Market Size, 2017-2028
        6.5.6 India Pediatric Respiratory Disease Therapeutics Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Pediatric Respiratory Disease Therapeutics Revenue, 2017-2028
        6.6.2 Brazil Pediatric Respiratory Disease Therapeutics Market Size, 2017-2028
        6.6.3 Argentina Pediatric Respiratory Disease Therapeutics Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Pediatric Respiratory Disease Therapeutics Revenue, 2017-2028
        6.7.2 Turkey Pediatric Respiratory Disease Therapeutics Market Size, 2017-2028
        6.7.3 Israel Pediatric Respiratory Disease Therapeutics Market Size, 2017-2028
        6.7.4 Saudi Arabia Pediatric Respiratory Disease Therapeutics Market Size, 2017-2028
        6.7.5 UAE Pediatric Respiratory Disease Therapeutics Market Size, 2017-2028
7 Players Profiles
    7.1 Novartis AG
        7.1.1 Novartis AG Corporate Summary
        7.1.2 Novartis AG Business Overview
        7.1.3 Novartis AG Pediatric Respiratory Disease Therapeutics Major Product Offerings
        7.1.4 Novartis AG Pediatric Respiratory Disease Therapeutics Revenue in Global Market (2017-2022)
        7.1.5 Novartis AG Key News
    7.2 Bayer AG
        7.2.1 Bayer AG Corporate Summary
        7.2.2 Bayer AG Business Overview
        7.2.3 Bayer AG Pediatric Respiratory Disease Therapeutics Major Product Offerings
        7.2.4 Bayer AG Pediatric Respiratory Disease Therapeutics Revenue in Global Market (2017-2022)
        7.2.5 Bayer AG Key News
    7.3 GSK
        7.3.1 GSK Corporate Summary
        7.3.2 GSK Business Overview
        7.3.3 GSK Pediatric Respiratory Disease Therapeutics Major Product Offerings
        7.3.4 GSK Pediatric Respiratory Disease Therapeutics Revenue in Global Market (2017-2022)
        7.3.5 GSK Key News
    7.4 Merck
        7.4.1 Merck Corporate Summary
        7.4.2 Merck Business Overview
        7.4.3 Merck Pediatric Respiratory Disease Therapeutics Major Product Offerings
        7.4.4 Merck Pediatric Respiratory Disease Therapeutics Revenue in Global Market (2017-2022)
        7.4.5 Merck Key News
    7.5 Boehringer Ingelheim
        7.5.1 Boehringer Ingelheim Corporate Summary
        7.5.2 Boehringer Ingelheim Business Overview
        7.5.3 Boehringer Ingelheim Pediatric Respiratory Disease Therapeutics Major Product Offerings
        7.5.4 Boehringer Ingelheim Pediatric Respiratory Disease Therapeutics Revenue in Global Market (2017-2022)
        7.5.5 Boehringer Ingelheim Key News
    7.6 Regeneron Pharmaceuticals
        7.6.1 Regeneron Pharmaceuticals Corporate Summary
        7.6.2 Regeneron Pharmaceuticals Business Overview
        7.6.3 Regeneron Pharmaceuticals Pediatric Respiratory Disease Therapeutics Major Product Offerings
        7.6.4 Regeneron Pharmaceuticals Pediatric Respiratory Disease Therapeutics Revenue in Global Market (2017-2022)
        7.6.5 Regeneron Pharmaceuticals Key News
    7.7 AstraZeneca
        7.7.1 AstraZeneca Corporate Summary
        7.7.2 AstraZeneca Business Overview
        7.7.3 AstraZeneca Pediatric Respiratory Disease Therapeutics Major Product Offerings
        7.7.4 AstraZeneca Pediatric Respiratory Disease Therapeutics Revenue in Global Market (2017-2022)
        7.7.5 AstraZeneca Key News
    7.8 Roche
        7.8.1 Roche Corporate Summary
        7.8.2 Roche Business Overview
        7.8.3 Roche Pediatric Respiratory Disease Therapeutics Major Product Offerings
        7.8.4 Roche Pediatric Respiratory Disease Therapeutics Revenue in Global Market (2017-2022)
        7.8.5 Roche Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Pediatric Respiratory Disease Therapeutics Market Opportunities & Trends in Global Market
    Table 2. Pediatric Respiratory Disease Therapeutics Market Drivers in Global Market
    Table 3. Pediatric Respiratory Disease Therapeutics Market Restraints in Global Market
    Table 4. Key Players of Pediatric Respiratory Disease Therapeutics in Global Market
    Table 5. Top Pediatric Respiratory Disease Therapeutics Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Pediatric Respiratory Disease Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Pediatric Respiratory Disease Therapeutics Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Pediatric Respiratory Disease Therapeutics Product Type
    Table 9. List of Global Tier 1 Pediatric Respiratory Disease Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Pediatric Respiratory Disease Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Pediatric Respiratory Disease Therapeutics Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Pediatric Respiratory Disease Therapeutics Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Pediatric Respiratory Disease Therapeutics Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Pediatric Respiratory Disease Therapeutics Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Pediatric Respiratory Disease Therapeutics Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Pediatric Respiratory Disease Therapeutics Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 30. Novartis AG Corporate Summary
    Table 31. Novartis AG Pediatric Respiratory Disease Therapeutics Product Offerings
    Table 32. Novartis AG Pediatric Respiratory Disease Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 33. Bayer AG Corporate Summary
    Table 34. Bayer AG Pediatric Respiratory Disease Therapeutics Product Offerings
    Table 35. Bayer AG Pediatric Respiratory Disease Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 36. GSK Corporate Summary
    Table 37. GSK Pediatric Respiratory Disease Therapeutics Product Offerings
    Table 38. GSK Pediatric Respiratory Disease Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 39. Merck Corporate Summary
    Table 40. Merck Pediatric Respiratory Disease Therapeutics Product Offerings
    Table 41. Merck Pediatric Respiratory Disease Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 42. Boehringer Ingelheim Corporate Summary
    Table 43. Boehringer Ingelheim Pediatric Respiratory Disease Therapeutics Product Offerings
    Table 44. Boehringer Ingelheim Pediatric Respiratory Disease Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 45. Regeneron Pharmaceuticals Corporate Summary
    Table 46. Regeneron Pharmaceuticals Pediatric Respiratory Disease Therapeutics Product Offerings
    Table 47. Regeneron Pharmaceuticals Pediatric Respiratory Disease Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 48. AstraZeneca Corporate Summary
    Table 49. AstraZeneca Pediatric Respiratory Disease Therapeutics Product Offerings
    Table 50. AstraZeneca Pediatric Respiratory Disease Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 51. Roche Corporate Summary
    Table 52. Roche Pediatric Respiratory Disease Therapeutics Product Offerings
    Table 53. Roche Pediatric Respiratory Disease Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Pediatric Respiratory Disease Therapeutics Segment by Type in 2021
    Figure 2. Pediatric Respiratory Disease Therapeutics Segment by Application in 2021
    Figure 3. Global Pediatric Respiratory Disease Therapeutics Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Pediatric Respiratory Disease Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Pediatric Respiratory Disease Therapeutics Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Pediatric Respiratory Disease Therapeutics Revenue in 2021
    Figure 8. By Type - Global Pediatric Respiratory Disease Therapeutics Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Pediatric Respiratory Disease Therapeutics Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Pediatric Respiratory Disease Therapeutics Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Pediatric Respiratory Disease Therapeutics Revenue Market Share, 2017-2028
    Figure 12. US Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Pediatric Respiratory Disease Therapeutics Revenue Market Share, 2017-2028
    Figure 16. Germany Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 17. France Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Pediatric Respiratory Disease Therapeutics Revenue Market Share, 2017-2028
    Figure 24. China Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 28. India Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Pediatric Respiratory Disease Therapeutics Revenue Market Share, 2017-2028
    Figure 30. Brazil Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Pediatric Respiratory Disease Therapeutics Revenue Market Share, 2017-2028
    Figure 33. Turkey Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Pediatric Respiratory Disease Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 37. Novartis AG Pediatric Respiratory Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Bayer AG Pediatric Respiratory Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. GSK Pediatric Respiratory Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Merck Pediatric Respiratory Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Boehringer Ingelheim Pediatric Respiratory Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Regeneron Pharmaceuticals Pediatric Respiratory Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. AstraZeneca Pediatric Respiratory Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Roche Pediatric Respiratory Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
62
Frequently Asked Questions
Pediatric Respiratory Disease Therapeutics Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Pediatric Respiratory Disease Therapeutics Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Pediatric Respiratory Disease Therapeutics Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports